New England Capital Financial Advisors’s Barinthus Biotherapeutics BRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42 | Hold |
45
| – | – | ﹤0.01% | 416 |
|
|
2025
Q1 | $44 | Sell |
45
-59
| -57% | -$58 | ﹤0.01% | 388 |
|
|
2024
Q4 | $126 | Hold |
104
| – | – | ﹤0.01% | 399 |
|
|
2024
Q3 | $124 | Hold |
104
| – | – | ﹤0.01% | 387 |
|
|
2024
Q2 | $146 | Hold |
104
| – | – | ﹤0.01% | 379 |
|
|
2024
Q1 | $248 | Hold |
104
| – | – | ﹤0.01% | 378 |
|
|
2023
Q4 | $384 | Hold |
104
| – | – | ﹤0.01% | 369 |
|
|
2023
Q3 | $322 | Hold |
104
| – | – | ﹤0.01% | 367 |
|
|
2023
Q2 | $215 | Hold |
104
| – | – | ﹤0.01% | 372 |
|
|
2023
Q1 | $233 | Hold |
104
| – | – | ﹤0.01% | 414 |
|
|
2022
Q4 | $282 | Buy |
+104
| New | +$282 | ﹤0.01% | 410 |
|